Generare

Generare company information, Employees & Contact Information

Explore related pages

Related company profiles:

Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation.

Company Details

Employees
22
Founded
-
Address
Rue Maillard, Paris,île-De-France 75011,france
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Paris, Île-de-France
Looking for a particular Generare employee's phone or email?

Generare Questions

News

Flagship’s two most-funded startups, Generate and Tessera, lay off employees - Endpoints News

Flagship’s two most-funded startups, Generate and Tessera, lay off employees Endpoints News

Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise - statnews.com

Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise statnews.com

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery - PR Newswire

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery PR Newswire

MD Anderson and Generate:Biomedicines to co-develop protein therapies for cancer using generative AI - MD Anderson Cancer Center

MD Anderson and Generate:Biomedicines to co-develop protein therapies for cancer using generative AI MD Anderson Cancer Center

Generate:Biomedicines Raises Largest Biotech Series C of 2023 - Genetic Engineering and Biotechnology News

Generate:Biomedicines Raises Largest Biotech Series C of 2023 Genetic Engineering and Biotechnology News

Novartis inks $1B-plus biobucks deal with Flagship's Generate - Fierce Biotech

Novartis inks $1B-plus biobucks deal with Flagship's Generate Fierce Biotech

25. Generate: Biomedicines - CNBC

25. Generate: Biomedicines CNBC

Generate Bio adds $370M for big push toward programmable protein medicines - MedCity News

Generate Bio adds $370M for big push toward programmable protein medicines MedCity News

Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI - BioSpace

Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI BioSpace

Roswell Park Comprehensive Cancer Center, Generate:Biomedicines Enter Into Collaboration Agreement to Accelerate Novel Cell Therapies For Oncology Using Generative AI - Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center, Generate:Biomedicines Enter Into Collaboration Agreement to Accelerate Novel Cell Therapies For Oncology Using Generative AI Roswell Park Comprehensive Cancer Center

Generate:Biomedicines opens the hood on its AI software for making proteins - Endpoints News

Generate:Biomedicines opens the hood on its AI software for making proteins Endpoints News

Generate Biomedicines opens cryo-EM lab to feed data back into its protein design algorithms - Chemical & Engineering News

Generate Biomedicines opens cryo-EM lab to feed data back into its protein design algorithms Chemical & Engineering News

Flagship-backed Generate raises $273M as its first drugs move to the clinic - BioPharma Dive

Flagship-backed Generate raises $273M as its first drugs move to the clinic BioPharma Dive

Generate Biomedicines raises $273 million in latest round of funding - The Boston Globe

Generate Biomedicines raises $273 million in latest round of funding The Boston Globe

Machine learning biotech raises $273 million in rare successful late-stage round - statnews.com

Machine learning biotech raises $273 million in rare successful late-stage round statnews.com

Generate raises $273M—$100M less than previous round—but a huge bounty - Fierce Biotech

Generate raises $273M—$100M less than previous round—but a huge bounty Fierce Biotech

Generate Raises $273M in Series C Financing with New Investors Amgen, NVIDIA - BioSpace

Generate Raises $273M in Series C Financing with New Investors Amgen, NVIDIA BioSpace

Novartis strikes AI drug development deal with Generate:Biomedicines - statnews.com

Novartis strikes AI drug development deal with Generate:Biomedicines statnews.com

Inside one startup’s quest to build proteins from scratch using artificial intelligence - statnews.com

Inside one startup’s quest to build proteins from scratch using artificial intelligence statnews.com

AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH COLLABORATION AGREEMENT - PR Newswire

AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH COLLABORATION AGREEMENT PR Newswire

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress - Morningstar

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress Morningstar

AI is 'not a panacea' for all drug discovery challenges, but partnerships can be for Generate - Fierce Biotech

AI is 'not a panacea' for all drug discovery challenges, but partnerships can be for Generate Fierce Biotech

Flagship Pioneering's Scientists Invent Machine Learning-Powered Platform to Generate Novel Biomedicines - PR Newswire

Flagship Pioneering's Scientists Invent Machine Learning-Powered Platform to Generate Novel Biomedicines PR Newswire

Amgen Strikes Nearly $2 Billion Deal for Protein Therapeutics - BioSpace

Amgen Strikes Nearly $2 Billion Deal for Protein Therapeutics BioSpace

Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration - Genetic Engineering and Biotechnology News

Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration Genetic Engineering and Biotechnology News

Generate:Biomedicines and Novartis link on protein therapeutics development - Yahoo Finance

Generate:Biomedicines and Novartis link on protein therapeutics development Yahoo Finance

Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer - Business Wire

Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer Business Wire

Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis - BioSpace

Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis BioSpace

Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration - Genetic Engineering and Biotechnology News

Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration Genetic Engineering and Biotechnology News

Assessment of a novel single-stage integrated dark fermentation-microbial fuel cell system coupled to proton-exchange membrane fuel cell to generate bio-hydrogen and recover electricity from wastewater - ScienceDirect.com

Assessment of a novel single-stage integrated dark fermentation-microbial fuel cell system coupled to proton-exchange membrane fuel cell to generate bio-hydrogen and recover electricity from wastewater ScienceDirect.com

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs - Fierce Biotech

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs Fierce Biotech

IQHQ Announces Early Lease Renewal and Extension with Generate:Biomedicines - Business Wire

IQHQ Announces Early Lease Renewal and Extension with Generate:Biomedicines Business Wire

Assessment of a novel single-stage integrated dark fermentation-microbial fuel cell system coupled to proton-exchange membrane fuel cell to generate bio-hydrogen and recover electricity from wastewater - ScienceDirect.com

Assessment of a novel single-stage integrated dark fermentation-microbial fuel cell system coupled to proton-exchange membrane fuel cell to generate bio-hydrogen and recover electricity from wastewater ScienceDirect.com

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs - TechCrunch

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs TechCrunch

Effect of different ash/organics and C/H/O ratios on characteristics and reaction mechanisms of sludge microwave pyrolysis to generate bio-fuels - ScienceDirect.com

Effect of different ash/organics and C/H/O ratios on characteristics and reaction mechanisms of sludge microwave pyrolysis to generate bio-fuels ScienceDirect.com

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development - Genetic Engineering and Biotechnology News

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development Genetic Engineering and Biotechnology News

Amgen, Generate Launch Up-to-$1.9B Protein Therapeutics Collaboration - Genetic Engineering and Biotechnology News

Amgen, Generate Launch Up-to-$1.9B Protein Therapeutics Collaboration Genetic Engineering and Biotechnology News

Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D. - Business Wire

Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D. Business Wire

Generate Biomedicines Expands Leadership Team With Addition of Sean Martin as Chief Legal Officer and General Counsel - Business Wire

Generate Biomedicines Expands Leadership Team With Addition of Sean Martin as Chief Legal Officer and General Counsel Business Wire

Generate Biomedicines Bolsters Leadership Team With the Addition of Jason Silvers, M.D., J.D., as Chief Financial Officer - Business Wire

Generate Biomedicines Bolsters Leadership Team With the Addition of Jason Silvers, M.D., J.D., as Chief Financial Officer Business Wire

Atlas Organics to Accelerate Growth of Commercial Composting Solutions Across North America in Innovative Combination with Generate Capital - Business Wire

Atlas Organics to Accelerate Growth of Commercial Composting Solutions Across North America in Innovative Combination with Generate Capital Business Wire

Generate Capital acquires Atlas Organics - Waste Today -

Generate Capital acquires Atlas Organics Waste Today -

Generate:Biomedicines Spearheads the Future of Generative AI in Medicine at J.P. Morgan Healthcare Conference - AIM Media House

Generate:Biomedicines Spearheads the Future of Generative AI in Medicine at J.P. Morgan Healthcare Conference AIM Media House

Horse manure to power Woolwich home of the King's Troop - BBC

Horse manure to power Woolwich home of the King's Troop BBC

Bantwal MLA’s farm converts wet waste into bio-CNG - Times of India

Bantwal MLA’s farm converts wet waste into bio-CNG Times of India

Palm Oil Wastes Used To Generate Bio-electricity - Gabungan Pengusaha Kelapa Sawit Indonesia (GAPKI)

Palm Oil Wastes Used To Generate Bio-electricity Gabungan Pengusaha Kelapa Sawit Indonesia (GAPKI)

Bio-medical waste rules now apply to non-allopathy centres, clinics as well - Times of India

Bio-medical waste rules now apply to non-allopathy centres, clinics as well Times of India

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant